MOUNTAIN VIEW, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced the Company plans to participate in the upcoming 30 th Annual Roth Conference in Orange County, CA.

IRIDEX's management is scheduled to present on Tuesday, March 13, 2018 at 11:00am PT.  Interested parties may access a live and archived webcast of the presentation at 

About IRIDEXIRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market.  The Company's proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions.  IRIDEX's current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases.  IRIDEX products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries.  For further information, visit the IRIDEX website at

Investor Relations ContactLynn Pieper Lewis or Leigh Salvo(415)

Primary Logo